| Pregabalin |
EU/1/04/279/014 |
LYRICA, Capsule, hard, 100, mg, Pack: 21 |
Pfizer Limited, Обединено Кралство |
Pfizer GmbH Arzneimittelwerk, Германия |
30.94 |
6.19 |
37.13 |
4% |
1.24 |
32.18 |
6.44 |
38.62 |
16% |
4.95 |
37.13 |
7.43 |
44.56 |
цената е заличена с решение КЦРР-1086/26.07.2012 |
КЦ-826/15.04.2009 |
30.04.2009 |
30.04.2009 |
Заличен |
718 |
| Pregabalin |
EU/1/04/279/011 |
LYRICA, Capsule, hard, 75, mg, Pack: 14 |
Pfizer Limited, Обединено Кралство |
Pfizer Manifacturing Deutschland GmbH, Germany. |
16.08 |
3.22 |
19.3 |
6% |
0.96 |
17.04 |
3.41 |
20.45 |
18% |
2.89 |
19.93 |
3.99 |
23.92 |
Промяна на обстоятелства и вписване на цената в регистъра на пределните цени с решение НСР-4228/30.07.2014 |
НСР-2203/20.12.2013 |
04.01.2014 |
04.01.2014 |
Заличен |
2382 |
| Pregabalin |
EU/1/04/279/011 |
LYRICA, Capsule, hard, 75, mg, Pack: 14 |
Pfizer Limited, Обединено Кралство |
Pfizer GmbH Arzneimittelwerk, Gödecke, Germany. |
16.43 |
3.29 |
19.72 |
6% |
0.99 |
17.42 |
3.48 |
20.9 |
18% |
2.96 |
20.38 |
4.08 |
24.46 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2382 |
| Pregabalin |
EU/1/04/279/011 |
LYRICA, Capsule, hard, 75, mg, Pack: 14 |
Pfizer Limited, Обединено Кралство |
Pfizer GmbH Arzneimittelwerk, Gödecke, Germany. |
16.72 |
3.34 |
20.06 |
6% |
1 |
17.72 |
3.54 |
21.26 |
18% |
3.01 |
20.73 |
4.15 |
24.88 |
|
КЦ-575/23.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
2382 |
| Mitotane |
EU/1/04/273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Corden Pharma Latina S.p.A., Via del Murillo, Km.2.800, 04010 Sermoneta, (Latina) Италия
CENTRE SPECIALITES PHARMACEUTIQUES, 76-78, avenue du Midi, 63800 COURNON, D’AUVERGNE, Франция |
932.99 |
186.6 |
1119.59 |
4% |
10 |
942.99 |
188.6 |
1131.59 |
16% |
25 |
967.99 |
193.6 |
1161.59 |
промяна на обстоятелства HCP-10212/15.09.2016 |
НСР-7889/25.01.2016.; НСР-12222/03.04.2017; НСР-15832/08.06.2018; НСР-17998/21.02.2019 |
08.03.2019 |
02.04.2019 |
Активен |
3202 |
| Mitotane |
EU/1/04/273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Corden Pharma Latina S.p.A., Via del Murillo, Km.2.800, 04010 Sermoneta, (Latina) Италия
CENTRE SPECIALITES PHARMACEUTIQUES, 76-78, avenue du Midi, 63800 COURNON, D’AUVERGNE, Франция |
943.61 |
188.72 |
1132.33 |
4% |
10 |
953.61 |
190.72 |
1144.33 |
16% |
25 |
978.61 |
195.72 |
1174.33 |
промяна на обстоятелства HCP-10212/15.09.2016 |
НСР-7889/25.01.2016.; НСР-12222/03.04.2017; НСР-15832/08.06.2018 |
23.06.2018 |
02.07.2018 |
Неактивен |
3202 |
| Mitotane |
EU/1/04/273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Corden Pharma Latina S.p.A., Via del Murillo, Km.2.800, 04010 Sermoneta, (Latina) Италия
CENTRE SPECIALITES PHARMACEUTIQUES, 76-78, avenue du Midi, 63800 COURNON, D’AUVERGNE, Франция |
949.42 |
189.88 |
1139.3 |
4% |
10 |
959.42 |
191.88 |
1151.3 |
16% |
25 |
984.42 |
196.88 |
1181.3 |
промяна на обстоятелства HCP-10212/15.09.2016 |
НСР-7889/25.01.2016.; НСР-12222/03.04.2017 |
18.04.2017 |
02.05.2017 |
Неактивен |
3202 |
| Mitotane |
EU/1/04/ 273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Corden Pharma Latina S.p.A., Via del Murillo, Km.2.800, 04010 Sermoneta, (Latina) Италия
CENTRE SPECIALITES PHARMACEUTIQUES, 76-78, avenue du Midi, 63800 COURNON, D’AUVERGNE, Франция |
964.3 |
192.86 |
1157.16 |
4% |
10 |
974.3 |
194.86 |
1169.16 |
16% |
25 |
999.3 |
199.86 |
1199.16 |
промяна на обстоятелства HCP-10212/15.09.2016 |
НСР-7889/25.01.2016. |
09.02.2016 |
02.11.2016 |
Неактивен |
3202 |
| Mitotane |
EU/1/04/ 273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Bristol-Myers Squibb S.p.A., Italy |
964.3 |
192.86 |
1157.16 |
4% |
10 |
974.3 |
194.86 |
1169.16 |
16% |
25 |
999.3 |
199.86 |
1199.16 |
|
НСР-7889/25.01.2016. |
09.02.2016 |
09.02.2016 |
Неактивен |
3202 |
| Mitotane |
EU/1/04/ 273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Bristol-Myers Squibb S.p.A., Italy |
1006.67 |
201.33 |
1208 |
4% |
10 |
1016.67 |
203.33 |
1220 |
16% |
25 |
1041.67 |
208.33 |
1250 |
|
НСР-6142/29.04.2015. |
14.06.2015 |
14.06.2015 |
Неактивен |
3202 |
| Mitotane |
EU/1/04/273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Bristol-Myers Squibb S.p.A., Italy |
1059.26 |
211.85 |
1271.11 |
4% |
10 |
1069.26 |
213.85 |
1283.11 |
16% |
25 |
1094.26 |
218.85 |
1313.11 |
|
НСР-4604/15.09.2014 |
30.09.2014 |
30.09.2014 |
Неактивен |
3202 |
| Mitotane |
EU/1/04/273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Bristol-Myers Squibb S.p.A., Italy |
1080.15 |
216.03 |
1296.18 |
4% |
10 |
1090.15 |
218.03 |
1308.18 |
16% |
25 |
1115.15 |
223.03 |
1338.18 |
корекц. Решение НСР-2806/17.02.2014 |
НСР-2213/20.12.2013 |
28.01.2014 |
28.01.2014 |
Неактивен |
3202 |
| Mitotane |
EU/1/04/273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Bristol-Myers Squibb S.p.A., Italy |
1102.91 |
220.58 |
1323.49 |
4% |
10 |
1112.91 |
222.58 |
1335.49 |
16% |
25 |
1137.91 |
227.58 |
1365.49 |
|
КЦРР-2035/21.01.2013 |
03.04.2013 |
03.04.2013 |
Неактивен |
3202 |
| Mitotane |
EU/1/04/273/001 |
Lysodren, Tablet, 500, mg, Pack: 100 |
Laboratoire HRA Pharma, Франция |
Bristol-Myers Squibb S.p.A., Italy |
1146.64 |
229.33 |
1375.97 |
4% |
10 |
1156.64 |
231.33 |
1387.97 |
16% |
25 |
1181.64 |
236.33 |
1417.97 |
|
КЦ-1512/19.04.2010 |
10.05.2010 |
10.05.2010 |
Неактивен |
3202 |
| Suxamethonium |
II-0971/01,11,2007 |
LYSTHENON, Solution for injection, 10 mg/ml - 5 ml, mg, Pack: 5 |
Takeda Austria GmbH, Австрия |
Takeda Austria GmbH, Austria |
10.68 |
2.14 |
12.82 |
6% |
0.64 |
11.32 |
2.26 |
13.58 |
18% |
1.92 |
13.24 |
2.65 |
15.89 |
промяна на обстоятелства НСР-2927/07.03.2014 |
КЦ-1463/16.03.2010 |
31.03.2010 |
31.03.2010 |
Активен |
905 |
| Suxamethonium |
II-0972/01,11,2007 |
LYSTHENON, Solution for injection, 20 mg/ml - 5, ml, Pack: 25 |
Takeda Austria GmbH, Австрия |
Takeda Austria GmbH, Austria |
29.1 |
5.82 |
34.92 |
6% |
1.75 |
30.85 |
6.17 |
37.02 |
18% |
5.24 |
36.09 |
7.22 |
43.31 |
промяна на обстоятелства НСР-2927/07.03.2014 |
КЦ-1463/16.03.2010; НСР-9505/09.06.2016 |
02.07.2016 |
02.07.2016 |
Заличен |
906 |
| Suxamethonium |
II-0972/01,11,2007 |
LYSTHENON, Solution for injection, 20 mg/ml - 5 ml, mg, Pack: 25 |
Takeda GmbH, Германия |
Takeda Austria GmbH, Austria |
29.1 |
5.82 |
34.92 |
6% |
1.75 |
30.85 |
6.17 |
37.02 |
18% |
5.24 |
36.09 |
7.22 |
43.31 |
промяна на обстоятелства НСР-2927/07.03.2014 |
КЦ-1463/16.03.2010 |
31.03.2010 |
31.03.2010 |
Неактивен |
906 |
| Levetiracetam |
20120084 |
Lyvam, Film coated tablet, 250, mg, Pack: 60 |
Alkaloid – INT d.o.o., Словения |
Alkaloid – INT d.o.o., Slandrova ulica 4 1231 Ljubljana-Crnuce,Словения |
24.25 |
4.85 |
29.1 |
6% |
1.46 |
25.71 |
5.14 |
30.85 |
18% |
4.37 |
30.08 |
6.02 |
36.1 |
цената се заличава HCР-393/03.07.2013 |
КЦРР-1567/05.11.2012 |
22.11.2012 |
22.11.2012 |
Заличен |
1423 |
| Levetiracetam |
20120086 |
Lyvam, Film coated tablet, 750, mg, Pack: 60 |
Alkaloid – INT d.o.o., Словения |
Alkaloid – INT d.o.o., Slandrova ulica 4 1231 Ljubljana-Crnuce,Словения |
74.71 |
14.94 |
89.65 |
4% |
2.99 |
77.7 |
15.54 |
93.24 |
16% |
11.95 |
89.65 |
17.93 |
107.58 |
цената се заличава HCР-395/03.07.2013 |
КЦРР-1567/05.11.2012 |
22.11.2012 |
22.11.2012 |
Заличен |
1421 |
| Levetiracetam |
20120085 |
Lyvam, Film coated tablet, 500, mg, Pack: 60 |
Alkaloid – INT d.o.o., Словения |
Alkaloid – INT d.o.o., Slandrova ulica 4 1231 Ljubljana-Crnuce,Словения |
49.46 |
9.89 |
59.35 |
4% |
1.98 |
51.44 |
10.29 |
61.73 |
16% |
7.91 |
59.35 |
11.87 |
71.22 |
цената се заличава HCР-396/03.07.2013 |
КЦРР-1567/05.11.2012 |
22.11.2012 |
22.11.2012 |
Заличен |
1422 |
| Levetiracetam |
20120087 |
Lyvam, Film coated tablet, 1000, mg, Pack: 60 |
Alkaloid – INT d.o.o., Словения |
Alkaloid – INT d.o.o., Slandrova ulica 4 1231 Ljubljana-Crnuce,Словения |
97.44 |
19.49 |
116.93 |
4% |
3.9 |
101.34 |
20.27 |
121.61 |
16% |
15.59 |
116.93 |
23.39 |
140.32 |
цената се заличава HCР-394/03.07.2013 |
КЦРР-1567/05.11.2012 |
22.11.2012 |
22.11.2012 |
Заличен |
1420 |
| Lixisenatide |
EU/1/12/811/003 |
Lyxumia, Solution for injection, 20 mcg – 3 ml, -, Pack: 2 pre-filled pens (dose 0.2 ml - 1 pen contains 14 doses) |
Sanofi-Aventis Groupe, Франция |
Sanofi-Aventis Deutschland GmbH, Германия |
114.26 |
22.85 |
137.11 |
4% |
4.57 |
118.83 |
23.77 |
142.6 |
16% |
18.28 |
137.11 |
27.42 |
164.53 |
|
НСР-8568/24.03.2016.; НСР-13094/06.07.2017; НСР-15133/02.03.2018; НСР-17136/01.11.2018 |
16.11.2018 |
02.12.2018 |
Активен |
3519 |
| Lixisenatide |
EU/1/12/811/003 |
Lyxumia, Solution for injection, 20 mcg – 3 ml, -, Pack: 2 pre-filled pens (dose 0.2 ml - 1 pen contains 14 doses) |
Sanofi-Aventis Groupe, Франция |
Sanofi-Aventis Deutschland GmbH, Германия |
114.75 |
22.95 |
137.7 |
4% |
4.59 |
119.34 |
23.87 |
143.21 |
16% |
18.36 |
137.7 |
27.54 |
165.24 |
|
НСР-8568/24.03.2016.; НСР-13094/06.07.2017; НСР-15133/02.03.2018 |
17.03.2018 |
02.04.2018 |
Неактивен |
3519 |
| Lixisenatide |
EU/1/12/811/003 |
Lyxumia, Solution for injection, 20 mcg – 3 ml, -, Pack: 2 pre-filled pens (dose 0.2 ml - 1 pen contains 14 doses) |
Sanofi-Aventis Groupe, Франция |
Sanofi-Aventis Deutschland GmbH, Германия |
115.84 |
23.17 |
139.01 |
4% |
4.63 |
120.47 |
24.09 |
144.56 |
16% |
18.53 |
139 |
27.8 |
166.8 |
|
НСР-8568/24.03.2016.; НСР-13094/06.07.2017 |
21.07.2017 |
02.08.2017 |
Неактивен |
3519 |
| Lixisenatide |
EU/1/12/811/003 |
Lyxumia, Solution for injection, 20 mcg – 3 ml, dose (0.2 ml) – 1 pen contains 14 doses, Pack: 2 |
Sanofi-Aventis Groupe, Франция |
Sanofi-Aventis Deutschland GmbH, Германия |
117.17 |
23.43 |
140.6 |
4% |
4.69 |
121.86 |
24.37 |
146.23 |
16% |
18.75 |
140.61 |
28.12 |
168.73 |
|
НСР-8568/24.03.2016. |
08.04.2016 |
08.04.2016 |
Неактивен |
3519 |